TechnoPulm
Disruptive Diagnostic Tool for Pulmonary-Function Testing
Company Overview
Snapshot
Founded in March 2021 by Shabty Negry and Igor Krivits, TechnoPulm operates with 1–10 employees. The company has raised $2 million across two funding rounds from one investor. In October 2024, TechnoPulm secured $2 million to advance its handheld device for full lung function tests.
Business overview
TechnoPulm is developing an advanced handheld diagnostics device that utilizes a remote telemedicine platform to perform comprehensive pulmonary examinations. The company's core product is the TechnoPulm system (STS), a patented, revolutionary spirometry and plethysmography handheld device designed for complete Pulmonary Function Testing (PFT) and accurate Lung Volume Measurements (LVM) in both clinical and home settings. This technology allows for all spirometry parameters to be taken in just 20 seconds of one exhaled breath, serving the health tech and life sciences sectors by providing digital medical diagnostics and medical devices.
Strategic signal
In October 2024, TechnoPulm raised $2 million to develop its handheld device for full lung function tests. This funding signals strong investor confidence in the company's innovative approach to pulmonary diagnostics and its potential to disrupt traditional testing methods by enabling comprehensive examinations outside of hospital settings. For investors, this indicates a significant step towards commercialization and market penetration in the digital health and medical device sectors.
Log in to access full profile ›Company Intelligence Q&A
- What is TechnoPulm's primary product?
- TechnoPulm's primary product is the TechnoPulm system (STS), a patented handheld device for complete Pulmonary Function Testing (PFT) and accurate Lung Volume Measurements (LVM) in both clinical and home settings.
- When was TechnoPulm founded and by whom?
- TechnoPulm was founded in March 2021 by co-founders Shabty Negry and Igor Krivits.
- What was a significant funding event for TechnoPulm?
- In October 2024, TechnoPulm raised $2 million to develop a handheld device capable of performing full lung function tests.
- What is the core technology behind TechnoPulm's device?
- The TechnoPulm system uses a revolutionary spirometry and plethysmography handheld device that can take all spirometry parameters in only 20 seconds of one exhaled breath.
- Which organization provided investment to TechnoPulm in May 2024?
- In May 2024, TechnoPulm received investment from the Israel Innovation Authority.